Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

1,2,3-Triacetyl-5-Deoxy-D-Ribose

    • Product Name 1,2,3-Triacetyl-5-Deoxy-D-Ribose
    • Alias Triacetyldeoxyribose
    • Einecs 231-665-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    545094

    Cas Number 62211-93-2
    Molecular Formula C13H18O8
    Molecular Weight 318.28 g/mol
    Iupac Name 1,2,3-Tri-O-acetyl-5-deoxy-D-ribose
    Appearance White to off-white solid
    Purity Typically ≥98%
    Melting Point 60-64°C
    Solubility Soluble in chloroform, ethyl acetate
    Storage Conditions Store at 2-8°C, protected from light and moisture
    Smiles CC(=O)O[C@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](OC(C)=O)CO1
    Synonyms 5-Deoxy-1,2,3-tri-O-acetyl-D-ribose

    As an accredited 1,2,3-Triacetyl-5-Deoxy-D-Ribose factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging is a 25g amber glass bottle with a secure screw cap, labeled with compound name, purity, and hazard information.
    Shipping 1,2,3-Triacetyl-5-Deoxy-D-Ribose is packed in sealed, chemically resistant containers to prevent moisture and contamination. It is shipped according to regulations for laboratory chemicals, with clear hazard labeling. Avoid extreme temperatures; handle with appropriate personal protective equipment. Shipping documentation includes safety data and emergency contact information to ensure safe transport and handling.
    Storage 1,2,3-Triacetyl-5-Deoxy-D-Ribose should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from direct sunlight and moisture. It should be kept at 2–8°C (refrigerated) and separated from incompatible substances such as strong oxidizers. Properly label the storage container and ensure access is limited to authorized personnel trained in chemical handling.
    Application of 1,2,3-Triacetyl-5-Deoxy-D-Ribose

    Applications of 1,2,3-Triacetyl-5-Deoxy-D-Ribose in Industrial Manufacturing

    As a direct manufacturer of 1,2,3-Triacetyl-5-Deoxy-D-Ribose, we supply this specialty carbohydrate intermediate into high-value sectors where strict compliance, controlled processing, and clear end-use requirements are fundamental. See below for in-depth application details across well-established downstream segments.

    1. Nucleoside Analog Synthesis for Pharmaceutical APIs

    This intermediate serves as a critical glycosyl donor in nucleoside analog synthesis, underpinning the manufacture of antiviral and anticancer agents. Its use enables the stereoselective construction of modified nucleoside scaffolds, a necessity in several current-generation active pharmaceutical ingredients (APIs). High-purity standards and sequential process controls are non-negotiable to meet regulatory expectations demanded by the global pharmaceutical sector.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP/NF/EP monographs for nucleoside drugs and intermediates
    • US FDA 21 CFR Part 210/211 (cGMP requirements for finished pharmaceuticals)
    • EU Directive 2011/62/EU on falsified medicines (traceability and supply chain)

    Typical usage ratio

    • Employed as glycosyl donor at a 1.05:1 to 1.3:1 molar ratio relative to aglycone base, with adjustment according to coupling yield and downstream hydrolysis efficiencies

    Downstream process integration

    • Introduced after protection and activation of the sugar moiety; participates in glycosylation reactions under Lewis acid catalysis, followed by deprotection and purification stages

    Final product types

    • Antiviral nucleoside APIs (e.g., anti-hepatitis B/C therapies)
    • Cytotoxic or immunomodulatory nucleoside drugs
    • Intermediate building blocks for further pharmaceutical synthesis

    2. Modified Nucleotide Synthesis for Oligonucleotide Drugs and Diagnostics

    The raw material is utilized in the synthesis of modified ribose backbones for nucleotide analogs applied in oligonucleotide therapeutics, siRNA, and molecular diagnostic reagents. The distinct deoxy-acetylated ribose unit is essential for developing nucleotide analogs with altered stability and cellular uptake. Such applications demand not only process purity but precise control of isomer and protecting group profiles throughout multi-step syntheses.

    Industry compliance standards

    • USP 40–NF 35 for oligonucleotide substances
    • ISO 13485:2016 for diagnostic reagent manufacturing
    • Ph. Eur guidelines on modified nucleotides for advanced medicinal products
    • US FDA QSR (21 CFR 820) for in vitro diagnostic production

    Typical usage ratio

    • Applied at 1.0:1 equivalent to nucleobase activating agent; ratios may vary slightly (±10%) based on target oligonucleotide sequence length and scale

    Downstream process integration

    • Feeds into solid-phase or solution-phase oligonucleotide synthesis as protected nucleotide precursor; subjected to sequential phosphoramidite coupling and post-synthetic deprotection

    Final product types

    • Antisense oligonucleotide drug substances
    • siRNA duplexes for gene silencing therapies
    • Probe oligonucleotides in PCR/RT-qPCR diagnostic kits
    • Research-use-modified nucleotides for gene editing and detection

    3. Intermediates for Carbohydrate-Based Prodrug Formulation

    This specialty sugar derivative functions as an intermediate in assembling carbohydrate-based prodrugs, where bioavailability or metabolic release profiles require precise glycosylation. Its unique acetylated structure enables chemists to introduce labile protecting groups tailored for targeted in vivo activation. This process faces rigorous quality and traceability demands, particularly for clinical-stage small molecule prodrugs.

    Industry compliance standards

    • ICH Q11: Development and manufacture of drug substances
    • US FDA IND/NDA submission (CMC section)
    • EU GMP Part II: Basic requirements for APIs
    • Current Good Laboratory Practice (cGLP) if used for preclinical batch synthesis

    Typical usage ratio

    • Varies from 0.9 to 1.2 equivalents per aglycone substrate, with batch ratio optimized for each target API’s glycosylation requirements

    Downstream process integration

    • Utilized post-active site functionalization of core scaffold; enters as glycosylation partner via catalyst-mediated acyl transfer reactions, followed by global deprotection and formulation into clinical samples

    Final product types

    • Carbohydrate-conjugated prodrug APIs (oral and injectable forms)
    • Masked therapeutic nucleoside analogs
    • Glycosylated targeted-release agents (oncology, anti-infective)

    4. Building Block in Specialty Chemical Synthesis for Research and Reference Standards

    This compound is adopted within research and analytical labs for preparation of isotopically labeled nucleoside and carbohydrate standards, as well as for synthetic route development in academic and industrial process R&D. Its tight specification and batch reproducibility support reliable synthesis of structure-confirmation standards utilized throughout regulated testing environments.

    Industry compliance standards

    • ISO 17034:2016 for reference material producers
    • ISO/IEC 17025:2017 for chemical laboratory accreditation
    • GLP (OECD Principles of Good Laboratory Practice)
    • PIC/S Guide to Good Practices for the Preparation of Medicinal Products

    Typical usage ratio

    • Integrated at 1.0–1.5 equivalents relative to isotopic labeling agent or analytical tag; batch size adjusted based on standard material’s required detection sensitivity

    Downstream process integration

    • Added after isotopic enrichment or precursor activation step; forms labeled nucleoside or deoxy-sugar for subsequent purification and calibration standard packaging

    Final product types

    • Analytical reference materials (for HPLC, LC-MS/MS calibration)
    • Stable isotope–labeled standards for clinical or forensic testing
    • Synthetic intermediates for academic research pipeline

    5. Key Precursor in Synthesis of Sugar-Modified Bioconjugates for Drug Delivery

    This raw material is leveraged to produce sugar-modified linkers and bioconjugates designed for drug delivery system construction. Its acetyl protection and deoxy modifications provide flexible sites for further conjugation, crucial for antibody-drug conjugates (ADCs) and targeted delivery vehicles. Manufacturing requires highly controlled, traceable supply chains and record-keeping to ensure product integration compatibility and regulatory audit-readiness.

    Industry compliance standards

    • US FDA Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products
    • EU GMP EudraLex Volume 4 (Annex 2: Biological medicinal products)
    • ICH Q9 Quality Risk Management
    • USP General Chapter <1047> on Supplier Qualification

    Typical usage ratio

    • Introduced at 1:1 molar stoichiometry relative to linker backbone or targeting ligand, with process adjustments for conjugation efficiency (±15%)

    Downstream process integration

    • Feeds into the modification route post-core linker synthesis, via direct conjugation or amidation; proceeds to coupling with peptides, antibodies, or nanoparticles, and subsequent purification for formulation

    Final product types

    • Drug delivery platform linkers (e.g., for ADCs or nanoparticle carriers)
    • Sugar-modified targeting ligands for receptor-specific vehicles
    • Glycoconjugate intermediates for biopharmaceutical assembly
    Free Quote

    Competitive 1,2,3-Triacetyl-5-Deoxy-D-Ribose prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    1,2,3-Triacetyl-5-Deoxy-D-Ribose: A Chemist’s Perspective

    Walking into the manufacturing area, the air always carries a hint of acetyl groups mingled with the notes of solvents and past syntheses. In the world of rare sugars and complex carbohydrates, producing 1,2,3-Triacetyl-5-Deoxy-D-Ribose takes experience and a problem-solving mindset. Our process has moved well past the hurdles common in older operations, focusing on easy isolation and purity that researchers and process chemists look for in down-the-line work.

    Understanding the Compound

    1,2,3-Triacetyl-5-Deoxy-D-Ribose stands out as a unique acetylated pentose derivative. It takes its backbone from D-ribose, a familiar sight to many in nucleic acid and pharmaceutical circles, but we’ve altered three hydroxyl sites with acetyl moieties and removed another. That strategic change means the sugar is no longer sticky or prone to rapid breakdown the way unprotected ribose can be in chemical processes. Each batch leaves our plant with the signal clarity of NMR, a tight melting point, and defined physical character—crucial for those who need clean reactions.

    Our Manufacturing Focus

    Producing this molecule is not a simple toss-it-in-the-pot synthesis. Our team honed the process using selectivity at every step, paying close attention to temperature profiles and agitation rates, always monitoring for any off-flavors in the chemical profile. This isn’t about mass-producing a one-size-fits-all raw material. Every batch undergoes full chromatography trace review. The white crystalline powder that leaves our lab is checked for organic volatility, particle behavior, and absence of sticky residuals. Recent runs have shown batch after batch above 99% assay, and our impurity profile supports demanding downstream use in drug candidate synthesis.

    Specifications and Quality

    Every customer request brings up the question about assay, water content, and residual solvents. For us, these aren’t just numbers. If you weigh out a scoop from a freshly opened drum, you’ll notice the free-flowing nature, no caking at standard temperature and humidity. Analytical methods are more than certificates—our operators run HPLC, GC and NMR on each lot. Chloride, sulfate and heavy metal residues rarely touch our specification floor, because we maintain raw material controls and stainless steel isolation to avoid leaching. Each run is tracked with instrument-driven data, capturing lot integrity at each stage of manufacture and fill. The compound typically exits our drying facility with moisture below 0.5% and no detectable residual acetic acid or other low-volatility organics.

    Use Cases, Not Just Theories

    Many buyers come in with questions around nucleoside analog synthesis—one of the main reasons for interest in this molecule. The triacetylated nature means the core ribose is protected enough to handle rigorous C-glycosylation, or to serve as an intermediate for further selective deacetylation and chain elaboration. We noticed university groups and pharmaceutical developers use our product as a starting block for antiviral research. The 5-deoxy motif creates a distinct chemical handle—not present in common D-ribose or D-deoxyribose—so analogs from this sugar often avoid rapid enzymatic breakdown, opening doors in modified oligos or therapeutic agents.

    In-house, we validate that the structure stands up to common Lewis acid and base conditions used in further transformations. Early feedback from partners indicated that minute residual acetyl migration could affect downstream purification, so we invested in low-temperature, controlled acetylation and immediate isolation. Consistent results across repeated synthetic campaigns become possible only when the building block acts the same way batch after batch. We’ve also supported radiolabeling applications and glycosyl donor preparation, but our main customers work in small molecule active pharmaceutical ingredient (API) development, where certainty and ease of use matter most.

    Key Differences from Other Sugars and Analogs

    There’s more to a pentose derivative than the number of acetyl groups. Buyers in the specialty carbohydrate segment often compare 1,2,3-Triacetyl-5-Deoxy-D-Ribose to triacetyl derivatives with no deoxy modification, or even to cheaper peracetylated ribose. Lab experience tells us the missing 5-hydroxyl group means protection patterns remain stable under common transformations, and selective deacetylation runs with improved yields in our customer’s hands. You won’t find stray hydroxy reactivity in the 5-position causing unwanted bonds or dead-end impurities. Taste-test this in a synthetic route and the heightened stability becomes obvious—intermediate breakdown drops, and downstream reductions are easier to control. That’s a direct impact for anyone optimizing small-molecule routes to novel nucleosides or enzyme-resistant oligos.

    Some buyers ask about cost: why not just use plain D-ribose or 1,2,3-tri-O-acetyl-D-ribose? Unmodified or incompletely protected sugars lead to order-of-magnitude higher side product formation, slow filtration, and increased waste costs for chromatographic cleanup. A look at failed pilot runs or gunked-up reactors in companies trying to minimize costs by substituting generic sugars tells the story. Decades working with these materials show that well-made triacetyl-5-deoxy ribose pays back in reliability and reduction of operational headaches. The difference is seen in analytical clarity and yield—researchers spot it after just a single trial run.

    Personal Experience Matters in Day-to-Day Operation

    Working on the shop floor, seeing operators run the lines or troubleshoot columns, we remember the impact on people as much as equipment. A reliable, low-dusting crystalline solid keeps cleanup low and prevents unnecessary downtime. It’s easier for everyone, from plant team to analytical chemist. Our chemists draw on years of hands-on troubleshooting, often tackling problems our customers face in their own synthetic campaigns—the nitty-gritty of off-white fractions, slow dissolutions, or batch-to-batch shifts in reactivity. Any catch in routine sampling is a lesson saved for the next run. Our QC staff come with decades in carbohydrate chemistry and know how to spot the subtle differences that separate real reproducibility from routine paper specs.

    Supporting Advanced Research and Manufacturing Goals

    We see global pharmaceutical and academic groups reaching out for transparent, supply-chain-stable specialty reagents. Customers usually make clear they need a partner who delivers authenticated materials, not just raw bulk. With this triacetyl-5-deoxy ribose, we address those needs through data-backed quality and direct customer support. If that means adjusting particle fineness for a filtration step, or modifying packaging to reduce static on high-volume delivery, we adjust on the fly. Feedback loops between our synthesis team, analysts, and shipping line give us a direct sense of what works and what holds up the next operation in a route. That’s not just good business—it helps keep high-purity research running without delays.

    A successful API process starts with a reliable building block. A small difference in impurity profile or slow dissolution can drive cost increases down the entire scale-up project. Our track record comes from decades-long focus on in-process sampling, real-time monitoring, and prompt communication with users. Keeping this product in line with those standards takes more than a new piece of equipment or purchased software. It means experienced hands on every lot, with a direct line back to the source operators. We stick with our methods because customers demand real physical properties—batch after batch, month to month, with no failed deliveries or sky-high impurity excursions.

    The Challenges Unique to This Product

    Scaling up 1,2,3-Triacetyl-5-Deoxy-D-Ribose production is not without its quirks. Chemistry aside, the compound brings its own quirks in granulation, acetyl migration, and effluent streams. Early days brought more stuck filters than we’d care to count, and we saw that storage temperature control became critical. Any exposure to light or high humidity risked slow deacetylation, clumping, or off-odor development—not the impression we want our brand associated with. Now, deploying closed-system handling, continuous real-time moisture readings, and temperature-controlled storage keeps every lot at spec, regardless of outside climate shifts. Common industry shortcuts—like flash drying or rapid precipitations—show their faults in this molecule, so we avoid them for consistent chemical integrity.

    Downstream, users frequently bring up the material’s ability to withstand reaction conditions. Our hands-on stability testing ensures acetyl groups sit tight through moderately basic or acidic conditions, opening synthetic routes that closed off with more finicky sugars. We run our own parallel synthetic tests, passing information and feedback up and down the pipeline. Our technical support brings details from real-world trials, not just literature recitations. That pays off especially for scale-ups and process optimization, where minor batch variation could balloon into delays or process failures for a customer working to clinical timelines.

    Fact-Based, Continuous Improvement

    Having a dedicated line for this product means retaining key staff with sector experience, not just shifting between generic carbohydrate runs. Corrections to process drift are driven by data as well as operator intuition. Some suppliers cut corners with unvetted recycled acetylating reagents or inconsistent raw D-ribose sources. We maintain source verification on all key reagents, and our purchasing agreements ensure backward traceability. No drum leaves the facility untraced, and QA can recall full source histories at any point in the warehouse or production lifecycle. This practice sets us apart from generic commodity cycles—our customers spot the difference not only in chemical specs, but in operational support and ease of documentation.

    Regulatory compliance always follows closely behind development. Our documentation package for 1,2,3-Triacetyl-5-Deoxy-D-Ribose builds on current regional, national, and international standards for specialty reagents, even though the compound itself is not classified as a controlled pharmaceutical intermediate. This thoroughness helps our partners pass regulatory hurdles without the cost and trouble that often comes from generic or poorly-documented supply. Feedback from regulatory specialists often singles out the direct traceability and batch-to-batch documentation as key differentiators that support smooth process development and risk management for pharma customers.

    Supporting the Future of Carbohydrate Chemistry

    The specialty sugar market is not driven by splashy ads or trend waves. It grows out of a steady push for quality, dependability, and engagement from all corners of the chemical industry. In the early days, our teams learned lessons from batch failures, scale-up setbacks, and demanding end-users who expected laboratory-level quality at plant scale. Investing in staff expertise, plant design, and transparent feedback cycles brought both challenges and rewards. Now, our 1,2,3-Triacetyl-5-Deoxy-D-Ribose serves as both a staple for research and a go-to for process scale-ups in nucleoside and modified oligosaccharide chemistry, with researchers trusting both our product and our know-how to keep projects on track.

    We don’t see this molecule as just another notch in a product catalog. Every lot prompts fresh rounds of sampling, instrument checks, and direct feedback with customers on their changing needs. Our team makes it a point to learn from each customer’s workflow and to help anticipate hurdles before they trip up a scaling run. Whether it’s a new analytical method or a fresh workaround for product handling or solubility, we test and refine based on real-world use, not just internal targets. This practice not only improves product value, but helps advance carbohydrate chemistry across the sector, supporting new therapeutic discoveries with each successful project and every trouble-free drum arriving at a customer’s site.

    The Bigger Picture: Building Reliability with Experience

    Over years of improvements, every piece of feedback became a stepping stone toward a stronger product and tighter manufacturing process. From day to day, we draw on both deep technical knowledge and hands-on troubleshooting to fine-tune every lot produced. Each drum of 1,2,3-Triacetyl-5-Deoxy-D-Ribose represents more than just chemical building blocks; it stands as lived experience, a reflection of lessons learned and a commitment to support research and industrial partners worldwide. Consistency, safety, and transparency aren’t just aspirations—they’re ground-level requirements in every batch, set by the expectations of the community we serve and the standards we hold ourselves to, every day on the line.